Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by StevenBirch


V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Is FDA submission material enough for an NR?

Sounds good Wildbird, maybe 2023 will be the year of TLT. wildbird1 wrote...

December 16, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:Is FDA submission material enough for an NR?

I am a complete layman here but I would think that with frequent consultation...

December 16, 2022

V.TLT

RE:RE:RE:RE:RE:Here's what I'M THINKING----

That sounds good to me, I can sell less in the near term and let more ride...

December 15, 2022

V.TLT

RE:RE:RE:RE:RE:Here's what I'M THINKING----

That's exactly what I was thinking, take some off the table then just...

December 15, 2022

V.TLT

RE:RE:RE:Here's what I'M THINKING----

I don't think there would be a buyout until they start to get well into...

December 15, 2022

V.TLT

RE:RE:Exposure & Awareness

I'm not going to bite on your disengenuous question. Infinity wrote...

December 9, 2022

V.TLT

Exposure & Awareness

Dr. Ashish Kamat speaking this morning at the Large Urology Group Practice...

December 9, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2 weeks: It’s all it took for Merck to get AA

Thanks Eog, analysts price targets mean absolutely nothing. Reminds me of...

December 7, 2022

V.TLT

RE:RE:Low volume today??

I guess Merck and Roche don't have you on speed dial, you are out of the...

December 6, 2022

V.TLT

RE:RE:Roche's possible deal, while displacing Merck's Keytruda

Maybe it starts with a JV for NMIBC and when they start to prove themselves...

December 6, 2022

V.TLT

RE:RE:The Dawg's stock analysis

Dawg I like your analysis except for one thing - PR. I don't think it has...

November 30, 2022

V.TLT

RE:RE:I know I already have Enough however !

That's what it seems like. They are waiting for 1 or 2 to reach the 450...

November 30, 2022

V.TLT

RE:RE:RE:RE:I see 0.34---pre market---

It's illegal to enter an order like that and pull it at the last minute...

November 30, 2022

V.TLT

RE:RE:RE:BTD application

Thanks Enriquesuave, a pretty good increase in the pace of newly treated may...

November 29, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Ten years ago we talked of 100 $ plus share price .

I think I explained why I think it is at $0.30 and if/when they come up with...

November 29, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:Ten years ago we talked of 100 $ plus share price .

Witholding data? Do you have proof, otherwise keep it to yourself. Not...

November 29, 2022

V.TLT

RE:We haven't---got a news release yet----but---

That would be great, my guess is they give us the update sometime after the...

November 28, 2022

V.TLT

RE:RE:RE:RE:RE:RE:N-803 had been granted Breakthrough designation. We will too

That's the plan Oil.

November 27, 2022

V.TLT

RE:RE:RE:RE:N-803 had been granted Breakthrough designation. We will too

My understanding is it's 20-25 patients so maybe there is an allowance...

November 27, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:Impending News

It sure seems like they have been tying up loose ends the last few weeks...

November 25, 2022